Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-06 · accession 0001628280-24-050620 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-10 | 2024-12-06 | LFCR | Josephs Paul | CEO, Dir | F - Tax | $7.15 | -11.8K | 542.7K | -2% | -$84.1K | |
| 2024-12-10 | 2024-12-06 | LFCR | Josephs Paul | CEO, Dir | A - Grant | $0.00 | +38.5K | 554.5K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-06 | F | D | 11,769 | $7.15 | 542,717 | D | — | — | (F1) Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the stock grant. |
| 2 | Common | Common Stock | 2024-12-06 | A | A | 38,461 | $0.00 | 554,486 | D | — | — |